Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fonds Vives II (University of Louvain, UCL)


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 5
Average round size
The average size of a deal this fund participated in
Portfolio companies 4
Lead investments 0
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Life Science
  • Biopharma

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Fonds Vives II (University of Louvain, UCL), startups are often financed by Wallonia Regional Government, SFPI-FPIM, S.R.I.W.. The meaningful sponsors for the fund in investment in the same round are SFPI-FPIM, S.R.I.W., Fund+. In the next rounds fund is usually obtained by curative ventures, SFPI-FPIM, S.R.I.W..

Among the most successful fund investment fields, there are Biotechnology, Health Care. Among the most popular portfolio startups of the fund, we may highlight ITeos Therapeutics, A-Mansia Biotech. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fonds Vives II (University of Louvain, UCL):
Typical Co-investors
Fonds Vives II (University of Louvain, UCL) is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fonds Vives II (University of Louvain, UCL):

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bio Capital Impact Fund Australia, Melbourne, Victoria
Bio Ritmo Brazil, São Paulo, Sao Paulo
Chimera Investment Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Energiefonds Utrecht Netherlands, Utrecht, Utrecht
Kaplan EdTech Accelerator New York, New York, United States
Laurel Capital Partners Pennsylvania, Radnor, United States
MoneyLion New York, New York, United States
Synergy Growth England, London, United Kingdom
Weed Ventures -
Ziyu Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Medical Device
$7M15 Dec 2021 Brussels, Brussels Hoofdstedelijk Gewest, Belgium


$7M28 May 2020 Leuven, Flemish Brabant, Belgium

ITeos Therapeutics

Health Care
$75M20 Jun 2018 Cambridge, Massachusetts, United States

A-Mansia Biotech

Drug Discovery
Life Science
$15M27 Apr 2018 Limburg

ITeos Therapeutics

Health Care
$10M03 May 2012 Cambridge, Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fonds Vives II (University of Louvain, UCL)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: